Increases in fibrosis-related gene transcripts in livers of dimethylnitrosamine-intoxicated rats

Journal of Biomedical Science

Volumn 11, Issue 3, 2004, Pages 408-417

  Hsu, Yi Chao ^a   Chiu, Yung Tsung ^b   Lee, Chang Yin ^a   Lin, Yun Lian ^c   Huang, Yi Tsau ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Smooth muscle actin; Connective tissue growth factor; Dimethylnitrosamine; Fibrosis; Tissue inhibitor of metalloproteinase 1; Transforming growth factor 1

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ALANINE AMINOTRANSFERASE; ALPHA ACTIN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; COLLAGEN; DIMETHYLNITROSAMINE; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FIBROGENESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOLOGY; INTOXICATION; LIVER; LIVER FIBROSIS; MALE; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; RAT STRAIN;

ACTINS; ANIMALS; BASE SEQUENCE; DIMETHYLNITROSAMINE; DNA PRIMERS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS; MALE; PROCOLLAGEN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 1842635414     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000077110     Document Type: Article

References (61)

1. Ala-Kokko L, Pihlajaniemi T, Myers JC, Kivirikko KI, Savolainen ER. Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J 244:75-79;1987.
2. Bissell DM, Roulot D, George J. Transforming growth factor β and the liver. Hepatology 34:859-867;2001.
3. Blobe GC, Schiemann WP, Lodish, HF. Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358;2000.
4. Buck M, Kim DJ, Houglum K, Hassanein T, Chojkier M. c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 278:G321-G328;2000.
5. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 324:933-940;1991.
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159;1987.
7. Colombato LA, Robin M, Pomier-Layrargues G, Huet P-M. Animal models of portal hypertension. In: Holstege A, Scholmerich J, Hahn E.G., eds. Portal Hypertension. Dordrecht, Kluwer Academic Publishers, 3-14;1995.
8. De Bleser PJ, Xu G, Rombouts K, Rogiers V, Geerts A. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. J Biol Chem 274:33881-33887;1999.
9. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J 13:1774-1786;1999.
10. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247-2250;2000.
11. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 38:S38-S53;2003.
12. Garcia-Trevijano ER, Iraburu MJ, Fontana L, Dominguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta- dependent mechanism in rat hepatic stellate cells. Hepatology 29:960-970;1999.
13. Gebhardt R. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Med 68:289-296;2002.
14. Groszmann RJ, Loureiro-Silva MR, Tsai M-H. The biology of portal hypertension. In: Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz, DA, eds. The Liver: Biology and Pathobiology, ed 4. Philadelphia, Lippincott Williams & Wilkins, 801-830;2001.
15. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7:469-480;1996.
16. Halliwell B, Gutteridge JMC. Free radicals, other reactive species and disease. In: Free Radicals in Biology and Medicine, ed 3. Oxford, Oxford University Press, 617-783;1999.
17. Hata J, Ikeda E, Uno H, Asano S. Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR. J Histochem Cytochem 50:1461-1468;2002.
18. Hayashi N, Kakimuma T, Soma Y, Grotendorst GR, Tamaki K, Harada M, Igarashi A. Connective tissue growth factor is directly related to liver fibrosis. Hepatogastroenterology 49:133-135;2002.
19. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 30:77-87;1999.
20. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 150:1647-1659;1997.
21. Huang Y-T, Lin H-C, Tsai J-F, Hou M-C, Lee S-D, Hong C-Y. Vascular hyporeactivity persists despite increased contractility after longterm administration of isosorbide dinitrate in portal hypertensive rats. J Hepatol 28:1037-1044;1998.
22. Huang Y-T, Hsu Y-C, Chen C-J, Liu C-T, Wei Y-H. Oxidative-stress-related changes in the livers of bile-duct-ligated rats. J Biomed Sci 10:170-178;2003.
23. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 65:166-176;2002.
24. Jeong DH, Jang JJ, Lee SJ, Lee JH, Lim IK, Lee MJ, Lee YS. Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide. J Gastroenterol 36:24-32;2001.
25. Jezequel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 5:174-181;1987.
26. Kang KW, Choi SH, Ha JR, Kim CW, Kim SG. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2- dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression. Chem Biol Interact 139:61-77;2002.
27. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 30:48-60;1999.
28. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct ligation: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65:305-311;1981.
29. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461-2468;1995.
30. Lopez-De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33:737-743;1985.
31. Lu X, Liu P, Liu C, Xu G, Wang X, Chen W, Li F. Role of hepatic sinusoidal endothelium injury in hepatic fibrogenesis induced by dimethylnitrosamine in rats (in Chinese). Zhonghua Gan Zang Bing Za Zhi 10:441-444;2002.
32. Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 28:1745-1750;2000.
33. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci 114:4359-4369;2001.
34. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277:11069-11076;2002.
35. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32:247-254;2000.
36. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology 26:624-633;1997.
37. Nieto N, Friedman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived oxygen species. Hepatology 35:62-73;2002.
38. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358;1979.
39. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R, Ratziu V, Bedossa P. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30:968-976;1999.
40. Paradis V, Dargere D, Bonvoust F, Vidaud M, Segarini P, Bedossa P. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 82:767-774;2002.
41. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Gentilini P, Dianzani MU. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 194:1044-1050;1993.
42. Pinzani M, Gentilini P. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Semin Liver Dis 19:397-410;1999.
43. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21:49-98;2000.
44. Rojkind M, Greenwel P. Pathophysiology of liver fibrosis. In: Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz, DA, eds. The Liver: Biology and Pathobiology. ed 4. Philadelphia, Lippincott Williams & Wilkins, 721-738;2001.
45. Sakaida I, Uchida K, Matsumura Y, Okita K. Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis. J Hepatol 28:471-479;1998.
46. Sakaida I, Hironaka K, Terai S, Okita K. Gadolinium chloride reverses dimethylnitrosamine (DMN)-induced rat liver fibrosis with increased matrix metalloproteinases (MMPs) of Kupffer cells. Life Sci 72:943-959;2003.
47. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576;1995.
48. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:372-374;1991.
49. Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG, Schuppan D. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 158:1239-1244;2001.
50. Shiba M, Shimizu I, Yasuda M, Ii K, Ito S. Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver 18:196-204;1998.
51. Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, Ridolfi F, Saccomanno S, Jezequel AM, Benedetti A. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 27:720-726;1998.
52. Tada S, Iwamoto H, Nakamuta M, Sugimoto R, Enjoji M, Nakashima Y, Nawata H. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol 34:529-536;2001.
53. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49-61;2002.
54. Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman SL, Gores GJ. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 37:87-95;2003.
55. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10:56-65;1990.
56. Vendemiale G, Grattagliano I, Caruso ML, Serviddio G, Valentini AM, Pirrelli M, Altomare E. Increased oxidative stress in dimethylnitrosamine- induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-alpha. Toxicol Appl Pharmacol 175:130-139;2001.
57. 2+ uptake coupled to electron transport in rat heart mitochondria. J Biol Chem 253:6379-6385;1978.
58. Wasser S, Ho JMS, Ang HK, Tan CEL. Salvia miltiorrhiza reduced experimentally-induced hepatic fibrosis in rats. J Hepatol 29:760-771;1998.
59. Wells RG. Fibrogenesis. V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 279:G845-G850;2000.
60. Williams EJ, Gaca MDA, Brigstock DR, Arthur MJP, Benyon RC. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol 32:754-761;2000.
61. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32:1248-1254;2000.